350
Participants
Start Date
June 16, 2017
Primary Completion Date
February 15, 2019
Study Completion Date
April 1, 2019
Sugammadex
Reversal of neuromuscular block Sugammadex dosage will be adjusted to body weight and PTC/TOF count at the time of reversal, and not administered until PTC at least 1. Dosage will be 4mg/kg if TOF = 0 and PTC ≥ 1; and 2 mg/kg if TOF ≥1.
Neostigmine
Neostigmine 50 micrograms/kg coupled with atropine 20 micrograms/kg or glycopyrrolate 5 micrograms/kg, to a maximum dose of neostigmine of 5.0 mg. The neostigmine should not be administered until the TOF has at least 3 twitches present.
Melbourne Health, Parkville
The Royal Womens Hospital, Parkville
Victorian Comprehensive Cancer Centre, Parkville
Northpark Private Hospital, Bundoora
Collaborators (1)
Melbourne Health
OTHER
Peter MacCallum Cancer Centre, Australia
OTHER
Royal Hospital For Women
OTHER
Northpark Private Hospital
UNKNOWN
University of Melbourne
OTHER